Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
7.4%
% of IXJ's 113 holdings also in IHE
23.5%
% of IHE's 34 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.1% | 22.8% | 8.1% |
|
JOHNSON & JOHNSON | 4.7% | 22.7% | 4.7% |
|
MERCK & CO. INC. | 4.5% | 5.0% | 4.5% |
|
PFIZER INC | 2.1% | 4.7% | 2.1% |
|
BRISTOL-MYERS SQUIBB CO | 1.4% | 4.5% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to IHE
|
UNITEDHEALTH GROUP INC | 6.5% |
 |
NOVO NORDISK A/S-B | 5.6% |
|
ABBVIE INC | 4.1% |
|
THERMO FISHER SCIENTIFIC INC | 3.0% |
 |
ASTRAZENECA PLC | 2.9% |
 |
NOVARTIS AG | 2.7% |
|
ABBOTT LABORATORIES | 2.6% |
|
ROCHE HOLDING LTD | 2.4% |
|
DANAHER CORP | 2.2% |
|
AMGEN INC | 2.0% |
IXJ Underweight Relative to IHE
|
JOHNSON & JOHNSON | -18.0% |
|
ELI LILLY & CO | -14.7% |
|
ROYALTY PHARMA PLC CLASS A | -4.6% |
|
VIATRIS, INC. | -4.3% |
|
CATALENT INC | -4.2% |
|
BRISTOL-MYERS SQUIBB CO | -3.1% |
 |
JAZZ PHARMACEUTICALS PLC | -3.0% |
|
ZOETIS INC | -3.0% |
|
INTRA-CELLULAR THERAPIES INC | -2.8% |
|
ELANCO ANIMAL HEALTH, INC. | -2.7% |